SB5
Samsung Bioepis
['psoriasis']
at 's #eadv2022, we'll be presenting the 3-year follow-up results of our #immunology #biosimilar for #psoriasis patients. click here to learn more: #1nn0vatingaccess 
We make high quality biologic medicines more accessible, more quickly. See our community guidelines: https://t.co/VDDbzPMJvF. #InnovatingAccess